{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:02:33Z","timestamp":1792414953738,"version":"4.4.0"},"reference-count":146,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2020.11754","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T01:54:20Z","timestamp":1592531660000},"page":"2058-2074","source":"Crossref","is-referenced-by-count":517,"title":["Cervical cancer in low and middle\u2011income countries (Review)"],"prefix":"10.3892","volume":"20","author":[{"given":"Rodney","family":"Hull","sequence":"first","affiliation":[{"name":"SA\u2011MRC\/UP Precision Prevention and Novel Drug Targets for HIV\u2011Associated Cancers Extramural Unit, Pan African Cancer Research Institute, Faculty of Health Sciences, University of Pretoria, Hatfield 0028, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mzwandile","family":"Mbele","sequence":"additional","affiliation":[{"name":"SA\u2011MRC\/UP Precision Prevention and Novel Drug Targets for HIV\u2011Associated Cancers Extramural Unit, Pan African Cancer Research Institute, Faculty of Health Sciences, University of Pretoria, Hatfield 0028, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tshepiso","family":"Makhafola","sequence":"additional","affiliation":[{"name":"SA\u2011MRC\/UP Precision Prevention and Novel Drug Targets for HIV\u2011Associated Cancers Extramural Unit, Pan African Cancer Research Institute, Faculty of Health Sciences, University of Pretoria, Hatfield 0028, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chindo","family":"Hicks","sequence":"additional","affiliation":[{"name":"Bioinformatics and Genomics Centre, School of Medicine, Department of Genetics, Louisiana State University, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao\u2011Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"National Cancer Centre, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Reis","sequence":"additional","affiliation":[{"name":"Molecular Oncology Research Centre, Barretos Cancer Hospital, Sao Paulo 14784\u2011400, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Mehrotra","sequence":"additional","affiliation":[{"name":"Indian Council of Medical Research, New Delhi, Delhi 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilungile","family":"Mkhize\u2011Kwitshana","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Kwazulu\u2011Natal, Durban, Kwazulu\u2011Natal 4013, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibson","family":"Kibiki","sequence":"additional","affiliation":[{"name":"East African Health Research Commission, East African Community, Bujumbura, Bujumbura Mairie 350, Burundi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bates","sequence":"additional","affiliation":[{"name":"Queen's Medical Centre, University of Nottingham, Nottingham, Nottinghamshire NG7 2UH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zodwa","family":"Dlamini","sequence":"additional","affiliation":[{"name":"SA\u2011MRC\/UP Precision Prevention and Novel Drug Targets for HIV\u2011Associated Cancers Extramural Unit, Pan African Cancer Research Institute, Faculty of Health Sciences, University of Pretoria, Hatfield 0028, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"key20220302134952_b1-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20220302134952_b2-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(14)70481-4","article-title":"Present status of human papillomavirus vaccine development and implementation","volume":"16","author":"Herrero","year":"2015","journal-title":"Lancet Oncol"},{"key":"key20220302134952_b3-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer","volume":"361","author":"Waggoner","year":"2003","journal-title":"Lancet"},{"key":"key20220302134952_b4-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e7098","DOI":"10.1590\/1414-431x20177098","article-title":"PCR-RFLP assay as an option for primary HPV test","volume":"51","author":"Golfetto","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"key20220302134952_b5-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"key":"key20220302134952_b6-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.cmi.2015.05.011","article-title":"Molecular methods for identification and characterization of novel papillomaviruses","volume":"21","author":"Kocjan","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key20220302134952_b7-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.gore.2017.07.009","article-title":"Cervical cancer control in HIV-infected women: Past, present and future","volume":"21","author":"Ghebre","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"key20220302134952_b8-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"key20220302134952_b9-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12939-018-0768-2","article-title":"Disparities in cervical screening participation: A comparison of Russian, Somali and Kurdish immigrants with the general Finnish population","volume":"17","author":"Idehen","year":"2018","journal-title":"Int J Equity Health"},{"key":"key20220302134952_b10-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.gore.2017.12.005","article-title":"Evidence-based improvisation: Facing the challenges of cervical cancer care in Uganda","volume":"24","author":"Swanson","year":"2018","journal-title":"Gynecol Oncol Rep"},{"key":"key20220302134952_b11-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"key":"key20220302134952_b12-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: A WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"key20220302134952_b13-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int J Cancer"},{"key":"key20220302134952_b14-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","article-title":"Global cancer in women: Burden and trends","volume":"26","author":"Torre","year":"2017","journal-title":"Cancer Epidemol Biomarkers Prev"},{"key":"key20220302134952_b15-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"key20220302134952_b16-ol-0-0-11754","article-title":"WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention","author":"World Health Organization","year":"2013"},{"key":"key20220302134952_b17-ol-0-0-11754","first-page":"160","article-title":"Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. In: Cancer screening in the European Union","author":"Karsa","year":"2008","journal-title":"Report on the implementation of the Council Recommendation on cancer screening"},{"key":"key20220302134952_b18-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s12885-018-4540-1","article-title":"Projected cervical cancer incidence in Swaziland using three methods and local survey estimates","volume":"18","author":"Ginindza","year":"2018","journal-title":"BMC Cancer"},{"key":"key20220302134952_b19-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"key20220302134952_b20-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.canep.2015.04.006","article-title":"Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications","volume":"39","author":"Sartorius","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"key20220302134952_b21-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.gore.2017.01.009","article-title":"Cervical cancer screening and treatment in Uganda","volume":"20","author":"Nakisige","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"key20220302134952_b22-ol-0-0-11754","article-title":"Cancer Today","author":"Ferlay","year":"2018"},{"key":"key20220302134952_b23-ol-0-0-11754","article-title":"GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012","author":"International Agency for Research on Cancer","year":"2012"},{"key":"key20220302134952_b24-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7196\/SAMJ.2018.v108i3.12627","article-title":"Estimating the burden of cervical disease among HIV-infected women accessing screening services in South Africa: A model-based analysis","volume":"108","author":"Chibwesha","year":"2018","journal-title":"S Afr Med J"},{"key":"key20220302134952_b25-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/cncr.26639","article-title":"Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)-positive and HIV-negative patients with locally advanced cervical carcinoma in South Africa","volume":"118","author":"Simonds","year":"2012","journal-title":"Cancer"},{"key":"key20220302134952_b26-ol-0-0-11754","article-title":"UNAIDS Terminology Guidelines","author":"UNAIDS"},{"key":"key20220302134952_b27-ol-0-0-11754","article-title":"Report on the global HIV\/AIDS epidemic. UNAIDS2002","author":"UNAIDS"},{"key":"key20220302134952_b28-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.gore.2018.06.006","article-title":"Improving quality of care and timely access to radiation therapy for patients with invasive cervical cancer at the National Cancer Institute Paraguay","volume":"25","author":"Jacobson","year":"2018","journal-title":"Gynecol Oncol Rep"},{"key":"key20220302134952_b29-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1016\/j.vaccine.2013.10.003","article-title":"Comprehensive control of human papillomavirus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"key20220302134952_b30-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"key20220302134952_b31-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","article-title":"The global burden of women's cancers: A grand challenge in global health","volume":"389","author":"Ginsburg","year":"2017","journal-title":"Lancet"},{"key":"key20220302134952_b32-ol-0-0-11754","first-page":"59","article-title":"New cervical cancer screening guidelines: Was the annual pap too much of a good thing?","volume":"4","author":"Fields","year":"2013","journal-title":"J Adv Pract Oncol"},{"key":"key20220302134952_b33-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"key20220302134952_b34-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"C28","DOI":"10.1016\/j.vaccine.2012.03.032","article-title":"Introducing human papillomavirus vaccines into the health system in South Africa","volume":"30","author":"Botha","year":"2012","journal-title":"Vaccine"},{"key":"key20220302134952_b35-ol-0-0-11754","article-title":"Cancer in South Africa 2014","author":"South African National Cancer Registry","year":"2014"},{"key":"key20220302134952_b36-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"S211","DOI":"10.1016\/S0020-7292(06)60036-2","article-title":"Cervical cancer: The South African perspective. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Denny","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"key20220302134952_b37-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.3851\/IMP2905","article-title":"Provision of antiretroviral therapy in South Africa: The nuts and bolts","volume":"19","author":"Bekker","year":"2014","journal-title":"Antivir Ther"},{"key":"key20220302134952_b38-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bpobgyn.2017.08.011","article-title":"Clinical implications of the interaction between HPV and HIV infections","volume":"47","author":"Dreyer","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key20220302134952_b39-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12879-015-1181-8","article-title":"Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status","volume":"15","author":"Mbulawa","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key20220302134952_b40-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"954","DOI":"10.7196\/SAMJ.2015.v105i11.10135","article-title":"Human papillomavirus (HPV) vaccination of adolescents in the South African private health sector: Lessons from the HPV demonstration project in KwaZulu-Natal","volume":"105","author":"Tathiah","year":"2015","journal-title":"S Afr Med J"},{"key":"key20220302134952_b41-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1177\/0956462415606252","article-title":"Characteristics and geographic distribution of HIV-positive women diagnosed with cervical cancer in Dar es Salaam, Tanzania","volume":"27","author":"Lovgren","year":"2016","journal-title":"Int J STD AIDS"},{"key":"key20220302134952_b42-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1634\/theoncologist.2013-0305","article-title":"Expanding cervical cancer screening and treatment in Tanzania: Stakeholders' perceptions of structural influences on scale-up","volume":"20","author":"McCree","year":"2015","journal-title":"Oncologist"},{"key":"key20220302134952_b43-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/NCC.0b013e3181efe69f","article-title":"Visual inspection with acetic acid in cervical cancer screening","volume":"34","author":"Ardahan","year":"2011","journal-title":"Cancer Nursing"},{"key":"key20220302134952_b44-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2393-11-36","article-title":"Antenatal care in practice: An exploratory study in antenatal care clinics in the Kilombero Valley, south-eastern Tanzania","volume":"11","author":"Gross","year":"2011","journal-title":"BMC Pregnancy Childbirth"},{"key":"key20220302134952_b45-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.gore.2019.05.008","article-title":"Cervical cancer in Tanzania: A systematic review of current challenges in six domains","volume":"29","author":"Runge","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"key20220302134952_b46-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1159\/000447575","article-title":"Prevention of cervix cancer in India","volume":"91","author":"Mishra","year":"2016","journal-title":"Oncology"},{"key":"key20220302134952_b47-ol-0-0-11754","first-page":"1107","article-title":"The present scenario of cervical cancer control and HPV epidemiology in India: An outline","volume":"12","author":"Senapathy","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20220302134952_b48-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.vaccine.2008.11.041","article-title":"Prevalence of human papillomavirus types in cervical and oral cancers in central India","volume":"27","author":"Gheit","year":"2009","journal-title":"Vaccine"},{"key":"key20220302134952_b49-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/jmv.23310","article-title":"Prevalence of human papillomavirus types in cervical lesions from women in rural Western India","volume":"84","author":"Deodhar","year":"2012","journal-title":"J Med Virol"},{"key":"key20220302134952_b50-ol-0-0-11754","first-page":"3663","article-title":"HPV and cervical cancer epidemiology-current status of HPV vaccination in India","volume":"17","author":"Chatterjee","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20220302134952_b51-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1258\/jrsm.2012.110343","article-title":"Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness","volume":"105","author":"Mattheij","year":"2012","journal-title":"J R Soc Med"},{"key":"key20220302134952_b52-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jso.24544","article-title":"Cervical cancer prevention and treatment in Latin America","volume":"115","author":"Lopez","year":"2017","journal-title":"J Surg Oncol"},{"key":"key20220302134952_b53-ol-0-0-11754","article-title":"Brazil human papillomavirus and related cancers, fact sheet 2018 ICO\/IARC information centre on HPV and cancer, 2018","author":"HPV information centre"},{"key":"key20220302134952_b54-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"55","DOI":"10.22359\/cswhi_7_4_08","article-title":"Cervical Cancer Screening: Awareness and knowledge in Brazil","author":"Napa","year":"2016","journal-title":"Clin Social Work Health Intervention"},{"key":"key20220302134952_b55-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12985-015-0342-0","article-title":"Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective","volume":"12","author":"Lorenzi","year":"2015","journal-title":"Virol J"},{"key":"key20220302134952_b56-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"key20220302134952_b57-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","article-title":"Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking","author":"Castellsagu\u00e9","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"key20220302134952_b58-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5317\/wjog.v2.i3.53","article-title":"Smoking and genital human papilloma virus infection in women attending cervical cancer screening in Greece","volume":"2","author":"Chatzistamatiou","year":"2013","journal-title":"World J Obstet Gynecol"},{"key":"key20220302134952_b59-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijgo.2012.03.028","article-title":"Risk factors for human papillomavirus infection among women in Portugal: The CLEOPATRE Portugal Study","volume":"118","author":"Pista","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"key20220302134952_b60-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","author":"International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2007","journal-title":"Int J Cancer"},{"key":"key20220302134952_b61-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"key20220302134952_b62-ol-0-0-11754","first-page":"57","article-title":"Multifactorial etiology of cervical cancer: A hypothesis","volume":"7","author":"Haverkos","year":"2005","journal-title":"MedGenMed"},{"key":"key20220302134952_b63-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.3389\/fmicb.2017.02253","article-title":"Co-carcinogenesis: Human papillomaviruses, coal tar derivatives, and squamous cell cervical cancer","volume":"8","author":"Haverkos","year":"2017","journal-title":"Front Microbiol"},{"key":"key20220302134952_b64-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"HPV in the etiology of human cancer","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"key":"key20220302134952_b65-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"S254","DOI":"10.1093\/carcin\/bgv039","article-title":"Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead","volume":"36","author":"Goodson","year":"2015","journal-title":"Carcinogenesis"},{"key":"key20220302134952_b66-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/ijc.1622","article-title":"Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras","volume":"97","author":"Velema","year":"2002","journal-title":"Int J Cancer"},{"key":"key20220302134952_b67-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12038-010-0038-y","article-title":"Human papillomavirus and tar hypothesis for squamous cell cervical cancer","volume":"35","author":"Bennett","year":"2010","journal-title":"J Biosci"},{"key":"key20220302134952_b68-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cas.12333","article-title":"Gist of Dr. Katsusaburo Yamagiwa's papers entitled \u2018Experimental study on the pathogenesis of epithelial tumors\u2019 (I to VI reports)","volume":"105","author":"Fujiki","year":"2014","journal-title":"Cancer Sci"},{"key":"key20220302134952_b69-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2105\/AJPH.57.5.815","article-title":"Epidemiology of cancer of the cervix. 3. Sexual characteristics of a cervical cancer population","volume":"57","author":"Rotkin","year":"1967","journal-title":"Am J Public Health Nations Health"},{"key":"key20220302134952_b70-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12920-015-0115-z","article-title":"Defining \u2018mutation\u2019 and \u2018polymorphism\u2019 in the era of personal genomics","volume":"8","author":"Karki","year":"2015","journal-title":"BMC Med Genomics"},{"key":"key20220302134952_b71-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"8913860","DOI":"10.1155\/2017\/8913860","article-title":"Cervical carcinogenesis and immune response gene polymorphisms: A review","volume":"2017","author":"Mehta","year":"2017","journal-title":"J Immunol Res"},{"key":"key20220302134952_b72-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1073274818803942","DOI":"10.1177\/1073274818803942","article-title":"LINC00673 rs11655237 polymorphism is associated with increased risk of cervical cancer in a Chinese population","volume":"25","author":"Wang","year":"2018","journal-title":"Cancer Control"},{"key":"key20220302134952_b73-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-017-0685-9","article-title":"Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p","volume":"16","author":"Lu","year":"2017","journal-title":"Mol Cancer"},{"key":"key20220302134952_b74-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/ng.3568","article-title":"Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation","volume":"48","author":"Zheng","year":"2016","journal-title":"Nat Genet"},{"key":"key20220302134952_b75-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.7150\/ijms.27505","article-title":"Significant association of long non-coding RNAs HOTAIR genetic polymorphisms with cancer recurrence and patient survival in patients with uterine cervical cancer","volume":"15","author":"Weng","year":"2018","journal-title":"Int J Med Sci"},{"key":"key20220302134952_b76-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mc.22261","article-title":"A functional lncRNA HOTAIR genetic variant contributes to gastric cancer susceptibility","volume":"55","author":"Pan","year":"2016","journal-title":"Mol Carcinog"},{"key":"key20220302134952_b77-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"43271","DOI":"10.18632\/oncotarget.14920","article-title":"The HOTAIR, PRNCR1 and POLR2E polymorphisms are associated with cancer risk: A meta-analysis","volume":"8","author":"Chu","year":"2017","journal-title":"Oncotarget"},{"key":"key20220302134952_b78-ol-0-0-11754","first-page":"5679","article-title":"microRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2","volume":"16","author":"Yang","year":"2018","journal-title":"Oncol Lett"},{"key":"key20220302134952_b79-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"9729","DOI":"10.1038\/s41598-019-46077-z","article-title":"Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility","volume":"9","author":"Pandey","year":"2019","journal-title":"Sci Rep"},{"key":"key20220302134952_b80-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.7314\/APJCP.2014.15.15.6145","article-title":"Expression of Toll-like receptor 9 increases with progression of cervical neoplasia in Tunisian women-a comparative analysis of condyloma, cervical intraepithelial neoplasia and invasive carcinoma","volume":"15","author":"Fehri","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20220302134952_b81-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2004.10.022","article-title":"Function of alternative splicing","volume":"344","author":"Stamm","year":"2005","journal-title":"Gene"},{"key":"key20220302134952_b82-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2777","article-title":"Mechanisms of alternative splicing regulation: Insights from molecular and genomics approaches","volume":"10","author":"Chen","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20220302134952_b83-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbadis.2008.09.017","article-title":"Alternative splicing and disease","volume":"1792","author":"Tazi","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"key20220302134952_b84-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3390\/genes9010009","article-title":"Signaling pathways driving aberrant splicing in cancer cells","volume":"9","author":"Gon\u00e7alves","year":"2017","journal-title":"Genes (Basel)"},{"key":"key20220302134952_b85-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"a016071","DOI":"10.1101\/cshperspect.a016071","article-title":"Origin of spliceosomal introns and alternative splicing","volume":"6","author":"Irimia","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20220302134952_b86-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.biocel.2007.02.016","article-title":"Alternative splicing in cancer: Noise, functional, or systematic?","volume":"39","author":"Skotheim","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"key20220302134952_b87-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1101\/gad.1048803","article-title":"Pre-mRNA splicing and human disease","volume":"17","author":"Faustino","year":"2003","journal-title":"Genes Dev"},{"key":"key20220302134952_b88-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.molonc.2013.10.004","article-title":"An integrative framework identifies alternative splicing events in colorectal cancer development","volume":"8","author":"Bisognin","year":"2014","journal-title":"Mol Oncol"},{"key":"key20220302134952_b89-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pharmthera.2012.08.005","article-title":"Alternative transcription and alternative splicing in cancer","volume":"136","author":"Pal","year":"2012","journal-title":"Pharmacol Ther"},{"key":"key20220302134952_b90-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e0130377","DOI":"10.1371\/journal.pone.0130377","article-title":"The associations between RNA splicing complex gene SF3A1 polymorphisms and colorectal cancer risk in a Chinese population","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"key20220302134952_b91-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"37750","DOI":"10.18632\/oncotarget.5647","article-title":"SF3A1 and pancreatic cancer: New evidence for the association of the spliceosome and cancer","volume":"6","author":"Tian","year":"2015","journal-title":"Oncotarget"},{"key":"key20220302134952_b92-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"key20220302134952_b93-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41388-017-0119-6","article-title":"SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-\u03baB-CD47 axis","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"key20220302134952_b94-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.3892\/or.2016.4749","article-title":"Tumor-suppressing roles of miR-214 and miR-218 in breast cancer","volume":"35","author":"Liu","year":"2016","journal-title":"Oncol Rep"},{"key":"key20220302134952_b95-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2016.01.021","article-title":"TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis","volume":"89","author":"Korneev","year":"2017","journal-title":"Cytokine"},{"key":"key20220302134952_b96-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12253-015-0009-6","article-title":"Evaluation of Toll-Like receptors 2\/3\/4\/9 gene polymorphisms in cervical cancer evolution","volume":"22","author":"Zidi","year":"2016","journal-title":"Pathol Oncol Res"},{"key":"key20220302134952_b97-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"17055","DOI":"10.1038\/sigtrans.2017.55","article-title":"The role of TLRs in cervical cancer with HPV infection: A review","volume":"2","author":"Yang","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"key20220302134952_b98-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.3389\/fimmu.2019.02388","article-title":"The role of TLRs in anti-cancer immunity and tumor rejection","volume":"10","author":"Urban-Wojciuk","year":"2019","journal-title":"Front Immunol"},{"key":"key20220302134952_b99-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00005-013-0220-7","article-title":"Toll-like receptors in human papillomavirus infection","volume":"61","author":"Zhou","year":"2013","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"key20220302134952_b100-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"344","DOI":"10.5732\/cjc.010.10456","article-title":"Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women","volume":"30","author":"Hasimu","year":"2011","journal-title":"Chin J Cancer"},{"key":"key20220302134952_b101-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"785825","DOI":"10.1155\/2012\/785825","article-title":"Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment","volume":"2012","author":"DeCarlo","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"key20220302134952_b102-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ijc.25400","article-title":"Association between toll-like receptor expression and human papillomavirus type 16 persistence","volume":"128","author":"Daud","year":"2011","journal-title":"Int J Cancer"},{"key":"key20220302134952_b103-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.4049\/jimmunol.178.5.3186","article-title":"TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16","volume":"178","author":"Hasan","year":"2007","journal-title":"J Immunol"},{"key":"key20220302134952_b104-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1084\/jem.20122394","article-title":"The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter","volume":"210","author":"Hasan","year":"2013","journal-title":"J Exp Med"},{"key":"key20220302134952_b105-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-2094-11-20","article-title":"Defense against HSV-1 in a murine model is mediated by iNOS and orchestrated by the activation of TLR2 and TLR9 in trigeminal ganglia","volume":"11","author":"Zolini","year":"2014","journal-title":"J Neuroinflammation"},{"key":"key20220302134952_b106-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1038\/oncsis.2016.49","article-title":"TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression","volume":"5","author":"Parroche","year":"2016","journal-title":"Oncogenesis"},{"key":"key20220302134952_b107-ol-0-0-11754","article-title":"Multiple exposures to poultry barn air and lipopolysaccharide synergistically increase the pulmonary expression of TLR-4 and IL-1\u03b2","author":"Kaur","year":"2019","journal-title":"J Occup Health"},{"key":"key20220302134952_b108-ol-0-0-11754","first-page":"236","article-title":"microRNAs: A newly described class of encoded molecules that play a role in health and disease","volume":"14","author":"Felekkis","year":"2010","journal-title":"Hippokratia"},{"key":"key20220302134952_b109-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20220302134952_b110-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/iep.12177","article-title":"miR-376c inhibits cervical cancer cell proliferation and invasion by targeting BMI1","volume":"97","author":"Deng","year":"2016","journal-title":"Int J Exp Pathol"},{"key":"key20220302134952_b111-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev Biol"},{"key":"key20220302134952_b112-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1038\/oncsis.2016.21","article-title":"MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression","volume":"5","author":"Fan","year":"2016","journal-title":"Oncogenesis"},{"key":"key20220302134952_b113-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"33229","DOI":"10.1038\/srep33229","article-title":"miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200","volume":"6","author":"Fang","year":"2016","journal-title":"Sci Rep"},{"key":"key20220302134952_b114-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.biopha.2016.07.050","article-title":"MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1","volume":"83","author":"Huang","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"key20220302134952_b115-ol-0-0-11754","first-page":"2812","article-title":"miR-372 promotes breast cancer cell proliferation by directly targeting LATS2","volume":"15","author":"Cheng","year":"2018","journal-title":"Exp Ther Med"},{"key":"key20220302134952_b116-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41598-017-00901-6","article-title":"Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression","volume":"7","author":"Liao","year":"2017","journal-title":"Sci Rep"},{"key":"key20220302134952_b117-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"14605","DOI":"10.1007\/s13277-016-5320-7","article-title":"miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer","volume":"37","author":"Lu","year":"2016","journal-title":"Tumour Biol"},{"key":"key20220302134952_b118-ol-0-0-11754","first-page":"657","article-title":"MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer","volume":"15","author":"Xia","year":"2018","journal-title":"Exp Ther Med"},{"key":"key20220302134952_b119-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e00335","DOI":"10.1042\/BSR20160062","article-title":"Dynamic regulation of uncoupling protein 2 expression by microRNA-214 in hepatocellular carcinoma","volume":"36","author":"Yu","year":"2016","journal-title":"Biosci Rep"},{"key":"key20220302134952_b120-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.3892\/etm.2017.4433","article-title":"microRNA-664 enhances proliferation, migration and invasion of lung cancer cells","volume":"13","author":"Zhu","year":"2017","journal-title":"Exp Ther Med"},{"key":"key20220302134952_b121-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3892\/etm.2017.4171","article-title":"MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1","volume":"13","author":"Chen","year":"2017","journal-title":"Exp Ther Med"},{"key":"key20220302134952_b122-ol-0-0-11754","first-page":"1136","article-title":"miR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer","volume":"7","author":"Zhu","year":"2017","journal-title":"Am J Cancer Res"},{"key":"key20220302134952_b123-ol-0-0-11754","first-page":"5535","article-title":"MicroRNA-217 functions as a tumor suppressor in cervical cancer cells through targeting Rho-associated protein kinase 1","volume":"16","author":"Dong","year":"2018","journal-title":"Oncoly Lett"},{"key":"key20220302134952_b124-ol-0-0-11754","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cncr.25065","article-title":"Cervical cancer prevention: New tools and old barriers","volume":"116","author":"Scarinci","year":"2010","journal-title":"Cancer"},{"key":"key20220302134952_b125-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1016\/S1470-2045(12)70598-3","article-title":"Improvement of pathology in sub-Saharan Africa","volume":"14","author":"Adesina","year":"2013","journal-title":"Lancet Oncol"},{"key":"key20220302134952_b126-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(15)00755-2","article-title":"Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: Key messages from Disease Control Priorities, 3rd edition","volume":"387","author":"Gelband","year":"2016","journal-title":"Lancet"},{"key":"key20220302134952_b127-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1470-2045(13)70048-2","article-title":"Planning cancer control in Latin America and the Caribbean","volume":"14","author":"Goss","year":"2013","journal-title":"Lancet Oncol"},{"key":"key20220302134952_b128-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1016\/S2214-109X(14)70237-2","article-title":"Cost-effectiveness of female human papillomavirus vaccination in 179 countries: A PRIME modelling study","volume":"2","author":"Jit","year":"2014","journal-title":"Lancet Glob Health"},{"key":"key20220302134952_b129-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"key":"key20220302134952_b130-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"FUTURE II Study Group","year":"2007","journal-title":"N Engl J Med"},{"key":"key20220302134952_b131-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"key20220302134952_b132-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e101114","DOI":"10.1371\/journal.pone.0101114","article-title":"Costs of introducing and delivering HPV vaccines in low and lower middle income countries: Inputs for GAVI policy on introduction grant support to countries","volume":"9","author":"Levin","year":"2014","journal-title":"PLoS One"},{"key":"key20220302134952_b133-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical-cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N Engl J Med"},{"key":"key20220302134952_b134-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijgo.2007.05.005","article-title":"Screening for cervical cancer in an African setting","volume":"98","author":"Cronj\u00e9","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"key20220302134952_b135-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1371\/journal.pmed.0050132","article-title":"Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities","volume":"5","author":"Gakidou","year":"2008","journal-title":"PLoS Med"},{"key":"key20220302134952_b136-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/01443610802484070","article-title":"Patient perception of cervical screening among women living with human immuno-deficiency virus infection attending an antiretroviral therapy clinic in urban South Africa","volume":"29","author":"Wake","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"key20220302134952_b137-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1200\/JCO.2013.53.1376","article-title":"Moving forward in HIV-associated cancer","volume":"32","author":"Gopal","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20220302134952_b138-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"21965","DOI":"10.18632\/oncotarget.25136","article-title":"Human papilloma virus: Global research architecture assessed by density-equalizing mapping","volume":"9","author":"Bruggmann","year":"2018","journal-title":"Oncotarget"},{"key":"key20220302134952_b139-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"e0149696","DOI":"10.1371\/journal.pone.0149696","article-title":"Uptake of cervical cancer screening and associated factors among women in Rural Uganda: A cross sectional study","volume":"11","author":"Ndejjo","year":"2016","journal-title":"PLoS One"},{"key":"key20220302134952_b140-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12905-017-0375-1","article-title":"Factors associated with cervical cancer screening participation among immigrants of Russian, Somali and Kurdish origin: A population-based study in Finland","volume":"17","author":"Idehen","year":"2017","journal-title":"BMC Women Health"},{"key":"key20220302134952_b141-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/bjc.2015.248","article-title":"Understanding cervical screening non-attendance among ethnic minority women in England","volume":"113","author":"Marlow","year":"2015","journal-title":"Br J Cancer"},{"key":"key20220302134952_b142-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12939-014-0062-x","article-title":"Community collaboration to increase foreign-born women's participation in a cervical cancer screening program in Sweden: A quality improvement project","volume":"13","author":"Olsson","year":"2014","journal-title":"Int J Equity Health"},{"key":"key20220302134952_b143-ol-0-0-11754","first-page":"16","article-title":"Challenges, solutions and future directions in the evaluation of service innovations in health care and public health","volume":"4","author":"Raine","year":"2016","journal-title":"Health Services and Delivery Researc"},{"key":"key20220302134952_b144-ol-0-0-11754","first-page":"79","article-title":"The interplay of health, migrant status and socioeconomic status in eight EU countries. Health inequalities and risk factors among migrants and ethnic minorities","volume":"1","author":"Karl-Trummer","year":"2012","journal-title":"COST Series Health Div"},{"key":"key20220302134952_b145-ol-0-0-11754","article-title":"Public health aspects of migrant health: a review of the evidence on health status for labour migrants in the European Region","author":"Simon","year":"2015"},{"key":"key20220302134952_b146-ol-0-0-11754","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/cam4.1089","article-title":"Cervical cancer screening in a low-resource setting: A pilot study on an HPV-based screen-and-treat approach","volume":"6","author":"Kunckler","year":"2017","journal-title":"Cancer Med"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:57:52Z","timestamp":1723060672000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2020.11754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":146,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6,19]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2020.11754","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]}}}